143 related articles for article (PubMed ID: 18070827)
1. Haemodynamic parameters of the hepatic artery and vein can detect liver metastases: assessment using contrast-enhanced ultrasound.
Zhou JH; Li AH; Cao LH; Jiang HH; Liu LZ; Pei XQ; Han F
Br J Radiol; 2008 Feb; 81(962):113-9. PubMed ID: 18070827
[TBL] [Abstract][Full Text] [Related]
2. Hepatic transit time analysis using contrast-enhanced ultrasound with BR1: A prospective study comparing patients with liver metastases from colorectal cancer with healthy volunteers.
Hohmann J; Müller C; Oldenburg A; Skrok J; Frericks BB; Wolf KJ; Albrecht T
Ultrasound Med Biol; 2009 Sep; 35(9):1427-35. PubMed ID: 19540656
[TBL] [Abstract][Full Text] [Related]
3. Quantitative diagnosis of early-stage liver cirrhosis with contrast-enhanced ultrasound--a clinical study.
Shi Y; Wang XH; Xia GC; Lei CG
Adv Clin Exp Med; 2012; 21(3):385-90. PubMed ID: 23214202
[TBL] [Abstract][Full Text] [Related]
4. Assessment of global liver blood flow with quantitative dynamic contrast-enhanced ultrasound.
Gauthier TP; Wasan HS; Muhammad A; Owen DR; Leen EL
J Ultrasound Med; 2011 Mar; 30(3):379-85. PubMed ID: 21357560
[TBL] [Abstract][Full Text] [Related]
5. Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography.
Li N; Ding H; Fan P; Lin X; Xu C; Wang W; Xu Z; Wang J
Ultrasound Med Biol; 2010 Jul; 36(7):1066-75. PubMed ID: 20620694
[TBL] [Abstract][Full Text] [Related]
6. Shorter hepatic transit time can suggest coming metastases: through-monitoring by contrast-enhanced ultrasonography?
Zhang H; He Y; Du L; Wu Y
J Ultrasound Med; 2010 May; 29(5):719-26. PubMed ID: 20427783
[TBL] [Abstract][Full Text] [Related]
7. Obliteration of gastric varices improves the arrival time of ultrasound contrast agents in hepatic artery and vein.
Furuichi Y; Moriyasu F; Sugimoto K; Taira J; Sano T; Miyata Y; Sofuni A; Itoi T; Nakamura I; Imai Y
J Gastroenterol Hepatol; 2013 Sep; 28(9):1526-31. PubMed ID: 23611144
[TBL] [Abstract][Full Text] [Related]
8. Reproducibility of quantitative assessment of altered hepatic hemodynamics with dynamic contrast-enhanced ultrasound.
Gauthier TP; Muhammad A; Wasan HS; Abel PD; Leen EL
J Ultrasound Med; 2012 Sep; 31(9):1413-20. PubMed ID: 22922621
[TBL] [Abstract][Full Text] [Related]
9. Hepatic vein transit time of SonoVue: a comparative study with Levovist.
Lim AK; Patel N; Eckersley RJ; Goldin RD; Thomas HC; Cosgrove DO; Taylor-Robinson SD; Blomley MJ
Radiology; 2006 Jul; 240(1):130-5. PubMed ID: 16720867
[TBL] [Abstract][Full Text] [Related]
10. Significance of duplex/colour Doppler sonography in hepatic arterial chemotherapy for patients with liver metastases from colorectal carcinoma.
Guadagni S; Pizzutilli A; Mancini E; Varrone A; Palumbo G; Amicucci G; Perri S; Deraco M; Fiorentini G
Eur J Surg Oncol; 2000 Jun; 26(4):381-6. PubMed ID: 10873360
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of regional hepatic perfusion (RHP) by contrast-enhanced ultrasound in patients with cirrhosis.
Berzigotti A; Nicolau C; Bellot P; Abraldes JG; Gilabert R; García-Pagan JC; Bosch J
J Hepatol; 2011 Aug; 55(2):307-14. PubMed ID: 21167236
[TBL] [Abstract][Full Text] [Related]
12. [Clinical value of contrast-enhanced ultrasound in evaluating portal hypertension in patients with decompensated liver cirrhosis].
Zhuang Y; Ding H; Han H; Mao F; Luo JJ; Chen SY; Wang WP
Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):270-4. PubMed ID: 27470625
[TBL] [Abstract][Full Text] [Related]
13. Hepatic Vein Arrival Time for Diagnosis of Liver Cirrhosis: A 10-Year Single-Center Experience With Contrast-Enhanced Sonography.
Abbattista T; Ridolfi F; Consalvo GT; Brunelli E
J Ultrasound Med; 2016 Oct; 35(10):2121-8. PubMed ID: 27503751
[TBL] [Abstract][Full Text] [Related]
14. Definition of contrast enhancement phases of the liver using a perfluoro-based microbubble agent, perflubutane microbubbles.
Shunichi S; Hiroko I; Fuminori M; Waki H
Ultrasound Med Biol; 2009 Nov; 35(11):1819-27. PubMed ID: 19713032
[TBL] [Abstract][Full Text] [Related]
15. Macro- and microcirculation patterns of intrahepatic blood flow changes in patients with hereditary hemorrhagic telangiectasia.
Schelker RC; Barreiros AP; Hart C; Herr W; Jung EM
World J Gastroenterol; 2017 Jan; 23(3):486-495. PubMed ID: 28210085
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of microbubble contrast-enhanced ultrasound in the diagnosis of hepatic artery occlusion after liver transplantation.
Berstad AE; Brabrand K; Foss A
Transpl Int; 2009 Oct; 22(10):954-60. PubMed ID: 19497067
[TBL] [Abstract][Full Text] [Related]
17. Application of ultrasonography in the diagnosis and treatment tracing of hepatocellular carcinoma-associated arteriovenous fistulas.
Li YY; Duan YY; Yan GZ; Lv FQ; Cao W; Cao TS; Yuan LJ
Liver Int; 2007 Aug; 27(6):869-75. PubMed ID: 17617131
[TBL] [Abstract][Full Text] [Related]
18. Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C.
Lim AK; Taylor-Robinson SD; Patel N; Eckersley RJ; Goldin RD; Hamilton G; Foster GR; Thomas HC; Cosgrove DO; Blomley MJ
Gut; 2005 Jan; 54(1):128-33. PubMed ID: 15591518
[TBL] [Abstract][Full Text] [Related]
19. Application of the Hepatic Transit Time (HTT) in Evaluation of Portal Vein Pressure in Gastroesophageal Varices Patients.
Lin YQ; Jiang B; Li HQ; Jin CX; Wang H
J Ultrasound Med; 2019 Sep; 38(9):2305-2314. PubMed ID: 30609088
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced ultrasound for the evaluation of hepatic artery stenosis after liver transplantation: potential role in changing the clinical algorithm.
Zheng RQ; Mao R; Ren J; Xu EJ; Liao M; Wang P; Lu MQ; Yang Y; Cai CJ; Chen GH
Liver Transpl; 2010 Jun; 16(6):729-35. PubMed ID: 20517906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
